Compare Johnson & Johnson (JNJ) vs NXP Semiconductors N.V. Common Stock (NXPI) Price & Performance

Johnson & JohnsonTrade

NXP Semiconductors N.V. Common StockTrade

Price performance (Past 24H)

Key statistics

Johnson & Johnson vs NXP Semiconductors N.V. Common Stock — how do they compare? Johnson & Johnson trades at $261.41 (market cap $618.09B), while NXP Semiconductors N.V. Common Stock trades at $227.52 (market cap $58.27B). The key difference: Johnson & Johnson is far larger — about 10.6× NXP Semiconductors N.V. Common Stock's market cap, and Johnson & Johnson pays the higher dividend (2.09%). Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and NXP Semiconductors N.V. Common Stock for 0 Days on average.

	JNJ	NXPI
Market Cap	$618.09B	$58.27B
Volume	6,050,983	3,950,702
Sector	Health	Technology
52-Week High	$278.43	$332.67
52-Week Low	$186.00	$184.19
Typical Hold Time	129 Days	0 Days
Enterprise Value	$646.37B	$66.38B
Dividend Yield	2.09%	1.76%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Johnson & Johnson

Johnson & Johnson (JNJ) trades at $261.44, up 1.16% with a bearish technical signal despite recent earnings beats. The company maintains strong fundamentals with $94.19B revenue, 21.48% net margin, and consistent dividend payments. Recent news highlights growth in the Innovative Medicine segment and positive analyst coverage with a $286.53 consensus target.

JNJ offers stable growth potential with diversified healthcare operations and robust profitability. Key risks include patent expirations, competitive pressures, and debt levels. Analyst consensus leans bullish with 52.5% buy ratings, though technical indicators suggest near-term caution. The stock presents a balanced opportunity for long-term investors seeking healthcare exposure.

NXP Semiconductors N.V. Common Stock

No Aura AI signal available yet.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

JNJ

82% Buy18% Sell

Avg holding period · 129 Days

NXPI

100% Buy0% Sell

Avg holding period · 0 Days

Top news

Latest headlines on both assets

JNJ

Johnson & Johnson Q3 earnings expected with 5% EPS drop but 5.8% revenue growthGordon Thompson · 12 hours agoNeutral Four Dividend Kings remain strong but PepsiCo's dividend payout is riskier than others.24/7 Wall Street · 14 hours agoNeutral New Phase 3 data show ICOTYDE provides lasting skin clearance in moderate-to-severe plaque psoriasis over two years.PRNewsWire · 16 hours agoBullish View details →

NXPI

Three chip and software giants paid dividends on Oct 8, with TSMC raising payouts, Salesforce modestly increasing, and NXP holding steady.24/7 Wall Street · 14 hours agoBullish View details →

About Johnson & Johnson

Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.

About NXP Semiconductors N.V. Common Stock

NXP Semiconductors designs semiconductor solutions for embedded applications. Its products serve automotive, industrial and IoT, mobile, and communications-infrastructure markets.